Integral Health Asset Management LLC increased its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the period. Integral Health Asset Management LLC’s holdings in Replimune Group were […]
Emerald Advisers LLC cut its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 18.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 963,041 shares of the company’s stock after selling 223,000 shares during the period. Emerald Advisers LLC […]
Replimune Group (NASDAQ:REPL – Get Rating) had its target price upped by HC Wainwright from $50.00 to $51.00 in a research report sent to investors on Monday morning, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at […]
Replimune Group (NASDAQ:REPL – Get Rating) had its price target raised by HC Wainwright from $50.00 to $51.00 in a research report released on Monday, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at ($0.88) EPS, Q4 […]
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) has received an average rating of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued ratings on the stock in the […]